Article Details

Avacta wins millions from deal targeting $15bn market

Retrieved on: 2021-01-07 17:57:39

Tags for this article:

Click the tags to see associated articles and topics

Avacta wins millions from deal targeting $15bn market. View article details on hiswai:

Excerpt

POINT Biopharma is licensing Avacta's pre|CISION FAP-sensitive activation platform for radiopharmaceuticals – radioisotopes bound to biological ...

Article found on: www.businessweekly.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up